Design studies that produce evidence.

ORIA helps research teams design clinical studies that generate regulatory-grade evidence before the first patient is enrolled.

Where Evidence Fails, and How ORIA Fixes It

We identified six main challenges the industry faces and how ORIA works to eliminate them.

Endpoints That Don’t Support the Claim

Weak publications
Limited regulatory acceptance
No payer relevance

Studies Misaligned with Regulatory Expectations

Delays
Rejection risk
Need for redesign

Populations That Don’t Reflect Real Patients

Poor external validity
Limited adoption
Weak real-world impact

Operational Complexity That Breaks Execution

Recruitment failure
Data inconsistency
Timeline overruns

Evidence That Doesn’t Support Market Access

Commercialization challenges
Limited reimbursement
Poor commercial impact

Fragmented Evidence Strategy

Inconsistent conclusions
Weak overall narrative
Limited decision-making value

THE PROBLEMS WE ARE SOLVING

Most studies fail before they even begin

Clinical research generates enormous volumes of data, yet many studies fail to produce evidence that regulators, clinicians, or payers can use.

This often occurs because studies are designed using disconnected documents and spreadsheets rather than structured systems.

These flaws are often discovered only after enrollment begins, when correcting them becomes costly or impossible.

WHY ORIA?

We cut the time and cost required to design strong clinical studies.

ORIA introduces structured architecture to clinical study design.

The platform connects claims, objectives, endpoints, populations, timing, and analysis strategies into a single system that evaluates whether a study can generate meaningful evidence.

Instead of discovering weaknesses during execution, teams can identify and correct them during study planning.

Evaluate

Whether a proposed study can generate credible, publishable evidence. The platform examines endpoints, statistical assumptions, and design structure to determine whether results will be interpretable and scientifically meaningful.

Assess

Whether study endpoints, populations, and design elements align with regulatory expectations. This helps ensure that evidence generated can support future regulatory submissions.

Identify

Design elements that may create operational risk during study execution. The platform highlights factors that could complicate recruitment, data collection, or trial conduct.

Detect

Weaknesses in study design that may prevent meaningful conclusions. This includes missing endpoints, inappropriate populations, or limitations that could undermine the value of the study.

PROTECTING YOUR DATA

Data Encryption

All data is encrypted in transit and at rest to protect sensitive research information.

Secure Cloud Infrastructure

ORIA is hosted on secure, modern cloud infrastructure designed for reliability, scalability, and data protection.